Suppr超能文献

儿童和青少年先天性肾上腺皮质增生症患者的骨密度。

Bone mineral density in children and adolescents with congenital adrenal hyperplasia.

机构信息

Universidade Federal do Rio de Janeiro (UFRJ), 21941-901 Rio de Janeiro, RJ, Brazil ; Ambulatório de Endocrinologia, Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), UFRJ, Rua Bruno Lobo No. 50, 21941-912 Rio de Janeiro, RJ, Brazil.

Universidade Federal do Rio de Janeiro (UFRJ), 21941-901 Rio de Janeiro, RJ, Brazil.

出版信息

Int J Endocrinol. 2014;2014:806895. doi: 10.1155/2014/806895. Epub 2014 Mar 6.

Abstract

Chronic glucocorticoid therapy is associated with reduced bone mineral density. In paediatric patients with congenital adrenal hyperplasia, increased levels of androgens could not only counteract this effect, but could also advance bone age, with interference in the evaluation of densitometry. We evaluate bone mineral density in paediatric patients with classic congenital adrenal hyperplasia taking into account chronological and bone ages at the time of the measurement. Patients aged between 5 and 19 years underwent radiography of the hand and wrist followed by total body and lumbar spine densitometry. Chronological and bone ages were used in the scans interpretation. In fourteen patients, mean bone mineral density Z-score of total body to bone age was -0.76 and of lumbar spine to bone age was -0.26, lower than those related to chronological age (+0.03 and +0.62, resp.). Mean Z-score differences were statistically significant (P = 0.004 for total body and P = 0.003 for lumbar spine). One patient was classified as having low bone mineral density only when assessed by bone age. We conclude that there was a reduction in the bone mineral density Z-score in classic congenital adrenal hyperplasia paediatric patients when bone age was taken into account instead of chronological age.

摘要

慢性糖皮质激素治疗与骨密度降低有关。在患有先天性肾上腺增生症的儿科患者中,雄激素水平升高不仅可以抵消这种作用,还可以促进骨龄提前,从而干扰骨密度的评估。我们评估了考虑到测量时的实际年龄和骨龄的经典先天性肾上腺增生症儿科患者的骨密度。5 至 19 岁的患者接受手部和腕部射线照相检查,然后进行全身和腰椎骨密度检查。在扫描解释中使用了实际年龄和骨龄。在 14 名患者中,全身与骨龄的平均骨矿物质密度 Z 评分为-0.76,腰椎与骨龄的平均骨矿物质密度 Z 评分为-0.26,低于与实际年龄相关的 Z 评分(分别为+0.03 和+0.62)。平均 Z 评分差异具有统计学意义(全身为 P=0.004,腰椎为 P=0.003)。仅当通过骨龄评估时,1 名患者被归类为患有低骨密度。我们的结论是,当考虑到骨龄而不是实际年龄时,经典先天性肾上腺增生症儿科患者的骨矿物质密度 Z 评分降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验